Details for Patent: 10,022,445

« Back to Dashboard

Which drugs does patent 10,022,445 protect, and when does it expire?

Patent 10,022,445 protects SECUADO and is included in one NDA.

This patent has thirty-eight patent family members in nine countries.

Summary for Patent: 10,022,445

Title:	Patch
Abstract:	In a patch comprising a support layer and an adhesive agent layer, the adhesive agent layer comprises free asenapine, a maleic acid alkali salt, and a rubber-based adhesive agent.
Inventor(s):	Atsushi Sonobe, Takashi Yasukochi, Yasunori Takada
Assignee:	Hisamitsu Pharmaceutical Co Inc
Application Number:	US14/416,983
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 10,022,445

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Hisamitsu	SECUADO	asenapine	SYSTEM;TRANSDERMAL	212268-001	Oct 11, 2019		RX	Yes	Yes			Y
Hisamitsu	SECUADO	asenapine	SYSTEM;TRANSDERMAL	212268-002	Oct 11, 2019		RX	Yes	No			Y
Hisamitsu	SECUADO	asenapine	SYSTEM;TRANSDERMAL	212268-003	Oct 11, 2019		RX	Yes	No			Y

Foreign Priority and PCT Information for Patent: 10,022,445

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2012-165793	Jul 26, 2012
Japan	2013-078583	Apr 4, 2013

PCT Information
PCT Filed	July 25, 2013	PCT Application Number:	PCT/JP2013/070197
PCT Publication Date:	January 30, 2014	PCT Publication Number:	WO2014/017595

International Family Members for US Patent 10,022,445

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
China	104487071
China	104487072
China	104507472
European Patent Office	2878298
European Patent Office	2878299
European Patent Office	2878300